Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

36.50

-0.49 (-1.32%)

At close: Aug 15, 2025, 4:00 PM

37.28

+0.78 (2.14%)

After-hours: Aug 15, 2025, 7:51 PM EDT

Caris Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-279.05	-281.89	-341.42	-320.83
Depreciation & Amortization	33.05	48.91	49	48.25
Other Amortization	13.43	7.05	5.38	2.65
Stock-Based Compensation	52.68	18.64	15.24	22.9
Other Operating Activities	59.36	-8.85	2.82	-16.43
Change in Accounts Receivable	20.13	-33.82	-15.08	-11.91
Change in Inventory	-4.67	5.46	-4.44	-11.1
Change in Accounts Payable	-4.77	-0.23	7.17	8.91
Change in Other Net Operating Assets	-22.57	-0.48	5.22	-8.16
Operating Cash Flow	-132.4	-245.2	-276.1	-285.71
Capital Expenditures	-8.19	-8.44	-22.32	-42.26
Investment in Securities	-	61.38	237.09	-240.73
Investing Cash Flow	-8.19	52.93	214.77	-282.99
Long-Term Debt Issued	-	199.98	191.31	-
Long-Term Debt Repaid	-	-0.16	-180.74	-0.96
Net Debt Issued (Repaid)	27.77	199.82	10.57	-0.96
Issuance of Common Stock	532.01	1.53	1.87	11.41
Other Financing Activities	3.66	-1.06	-2.3	-
Financing Cash Flow	683	200.29	10.13	10.45
Foreign Exchange Rate Adjustments	0.08	-0	0.06	0
Net Cash Flow	542.49	8.02	-51.13	-558.25
Free Cash Flow	-140.59	-253.64	-298.42	-327.96
Free Cash Flow Margin	-26.33%	-61.52%	-97.48%	-126.88%
Free Cash Flow Per Share	-3.27	-7.15	-8.54	-9.83
Cash Interest Paid	49.02	49.02	15.78	24.24
Levered Free Cash Flow	-	-143.65	-178.04	-
Unlevered Free Cash Flow	-	-119.44	-163.66	-
Change in Working Capital	-11.88	-29.07	-7.13	-22.26

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q